Skip to main content

Peer Review reports

From: Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker

Original Submission
10 Nov 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
24 Dec 2022 Reviewed Reviewer Report
27 Dec 2022 Reviewed Reviewer Report
10 Jan 2023 Author responded Author comments - Laifeng Ren
Resubmission - Version 3
10 Jan 2023 Submitted Manuscript version 3
18 Jan 2023 Author responded Author comments - Laifeng Ren
Resubmission - Version 4
18 Jan 2023 Submitted Manuscript version 4
2 Feb 2023 Author responded Author comments - Laifeng Ren
Resubmission - Version 5
2 Feb 2023 Submitted Manuscript version 5
9 Feb 2023 Author responded Author comments - Laifeng Ren
Resubmission - Version 6
9 Feb 2023 Submitted Manuscript version 6
18 Feb 2023 Reviewed Reviewer Report
13 Mar 2023 Reviewed Reviewer Report
19 Mar 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
20 Mar 2023 Editorially accepted
10 Apr 2023 Article published 10.1186/s12885-023-10755-z

You can find further information about peer review here.

Back to article page